SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000912057-96-010356
Filing Date
1996-05-20
Accepted
1996-05-20 00:00:00
Documents
7
Period of Report
1996-03-31
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q 10-Q 37389
2 AGREEMENT BETWEEN ARRIS & KABI PHAR. AB EX-10.33 6089
3 RESEARCH & LICENSE AGRMT BETWEEN ARRIS & AMGEN EX-10.34 7246
4 AGRMNT BETWEEN ARRIS & PHARMACIA & UPJOHN EX-10.35 29858
5 AGRMNT BETWEEN ARRIS & SHELTON EX-10.36 2269
6 FIN. AGRMNT BETWEEN HAMBRECHT & QUIST EX-10.37 136266
7 AMENDMENT TO LEASE SCHEDULE EX-10.38 2444
  Complete submission text file 0000912057-96-010356.txt   222339
Mailing Address 385 OYSTER POINT BLVD SUITE 3 SOUTH SAN FRANCISCO CA 94080
Business Address 385 OYSTER POINT BLVD SUITE 3 SOUTH SAN FRANCISCO CA 94080 4157378600
ARRIS PHARMACEUTICAL CORP/DE/ (Filer) CIK: 0000913056 (see all company filings)

IRS No.: 222969941 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-22788 | Film No.: 96569777
SIC: 2834 Pharmaceutical Preparations